Dasatinib
- Product NDC
- 70377-088
- 11-digit product format
- 703770088
- Labeler code
- 70377
- Product ID
- 70377-088_6718ab7c-7205-4927-4055-0ce76dfca7ac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dasatinib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Biocon Pharma Inc.
- Application
- ANDA217217
- Marketing category
- ANDA
- Marketing start
- 2025-03-03
- Substance
- DASATINIB
- Active strength
- 140 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dasatinib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DASATINIB | 140 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | RBZ1571X5H |
| Rxcui | 643105, 643107, 643109, 799047, 1045402, 1045406 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70377-088-11 | Dasatinib | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70377-088 | DASATINIB (DASATINIB) TABLET, FILM COATED DASATINIB (DASATINIB) TABLET, FILM COATED [BIOCON PHARMA INC.] | 7 | Current NDC, 1 package rows | 20250306_76e1833c-e105-5a3d-0f01-1330d8cc7ae1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 70377-088-11 | 70377008811 | 30 TABLET, FILM COATED in 1 BOTTLE (70377-088-11) | 2025-03-03 | No | No | Historical |